Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
National HealthcareFRA:HTW -2.11%71 Return-on-Tangible-Asset is 12.06% as of Jun. 2026, which is 112% above its 10-year median of 5.69. GuruFocus rates FRA:HTW with a GF Score™ of 71/100 and a GF Value™ of €111.35. The stock has 5 warning signs investors should review. Among 680 Healthcare Providers & Services companies, National Healthcare ranks better than 81.32% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. National Healthcare's annualizedNet Income for the quarter that ended in Jun. 2026 was €140 Mil. National Healthcare's average total tangible assets for the quarter that ended in Jun. 2026 was €1,161 Mil. Therefore, National Healthcare's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 12.06%.
The historical rank and industry rank for National Healthcare's Return-on-Tangible-Asset or its related term are showing as below:
FRA:HTW'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 1.93 Med: 5.69 Max: 10.79
Current: 10.36
During the past 13 years, National Healthcare's highest Return-on-Tangible-Asset was 10.79%. The lowest was 1.93%. And the median was 5.69%.
FRA:HTW's Return-on-Tangible-Asset is ranked better than 81.32% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 2.66
vs FRA:HTW: 10.36
National Healthcare (FRA:HTW) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
National Healthcare Return-on-Tangible-Asset Related Terms
National Healthcare Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for National Healthcare's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
National Healthcare Return-on-Tangible-Asset Chart
FRA:HTW vs BKD, OPCH, ACHC: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, National Healthcare's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
National Healthcare Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, National Healthcare's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where National Healthcare's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 12.06% mean?
National Healthcare (FRA:HTW) has a Return-on-Tangible-Asset of 12.06% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on National Healthcare and its competitors. This is 112% above median its historical median of 5.69. Over the past decade, National Healthcare's Return-on-Tangible-Asset has ranged from 1.93 to 10.79. According to the industry distribution chart, National Healthcare ranks #127 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 18.7%.
Is National Healthcare's Return-on-Tangible-Asset too high?
National Healthcare's current Return-on-Tangible-Asset of 12.06% is 112% above median its 10-year median of 5.69. Over the past 10 years, this metric has ranged from a low of 1.93 to a high of 10.79. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.66. National Healthcare's value of 12.06% is 353.4% above this industry median. Based on the distribution chart, National Healthcare ranks #127 out of 680 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, National Healthcare has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does National Healthcare's Return-on-Tangible-Asset compare to BKD and OPCH?
According to the Healthcare Providers & Services industry distribution chart, National Healthcare ranks #127 out of 680 companies for Return-on-Tangible-Asset. This places National Healthcare in the top 19% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.66. National Healthcare's value of 12.06% is 353.4% above this benchmark. Historically, National Healthcare's own Return-on-Tangible-Asset has ranged from 1.93 to 10.79 over the past decade. While the company's 10-year median is 5.69 vs. the industry median of 2.66, National Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.66, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. National Healthcare's current Return-on-Tangible-Asset of 12.06% is 353.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on National Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. National Healthcare's current Return-on-Tangible-Asset is 12.06%, which is 112% above median its own 10-year median of 5.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is National Healthcare stock overvalued right now?
National Healthcare (FRA:HTW) has a current Return-on-Tangible-Asset of 12.06%. The stock's GF Value™ is €111.35, compared to a current price of €186.00 — trading 67% above its estimated fair value. The current Return-on-Tangible-Asset is 12.06%, which is 112% above median its 10-year median of 5.69 and 353.4% above the Healthcare Providers & Services industry median of 2.66. National Healthcare's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For National Healthcare (FRA:HTW), the current Return-on-Tangible-Asset is 12.06% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is National Healthcare (FRA:HTW) Overvalued in 2026?
Based on GuruFocus' analysis, National Healthcare stock appears to be overvalued.
The current stock price of €186.00 is trading 67% above its estimated GF Value™ of €111.35.
Key valuation signals for FRA:HTW:
Return-on-Tangible-Asset: 12.06% (112% above median its 10-year median of 5.69)
GF Value™: €111.35 vs. price of €186.00 (67% above fair value)
Industry Position: 353.4% above the Healthcare Providers & Services median (#127 of 680)
No single metric tells the full story. See the FRA:HTW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.
71GF Score
Get the complete analysis for FRA:HTW
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HTW has been successfully added to your 
